Intermediate for Afatinib. Afatinib (trade name: Gilotrif) is an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2) for the treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC). Afatinib has been approved by the U.S Food and Drug Administration on July 12, 2013.


Product Name:                  (S)-Tetrahydrofuran-3-ol

Synonyms:                         N/A

CAS Number:                     86087-23-2

Molecular Weight:            88.106

Molecular Formula:          C4H8O2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O[C@@H]1COCC1


  • $138.00
  • Ex Tax: $138.00

Available Options